Horizon Pharma Cash from Investing Quarterly:
-0.324M for Dec. 31, 2012Horizon Pharma Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -0.324M |
| Sept. 30, 2012 | -0.019M |
| June 30, 2012 | -0.91M |
| March 31, 2012 | -0.133M |
| Dec. 31, 2011 | -1.455M |
| Sept. 30, 2011 | -0.663M |
| June 30, 2011 | 0.005M |
| March 31, 2011 | -0.041M |
| Dec. 31, 2010 | -0.185M |
| Sept. 30, 2010 | -0.054M |
| June 30, 2010 | 5.82M |
| March 31, 2010 | -0.006M |
| Dec. 31, 2009 | -0.40M |
| Sept. 30, 2009 | -0.026M |
| June 30, 2009 | 0.188M |
| March 31, 2009 | -0.119M |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
HZNP Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Rigel Pharmaceuticals | -108.29M |
| Sagent Pharmaceuticals | -6.651M |
| Valeant Pharmaceuticals International | -234.90M |
HZNP Cash from Investing Quarterly Rankings
| Overall |
79th percentile 1548 of 7590 |
| Sector |
56th percentile 281 of 651 in Healthcare |
| Industry |
60th percentile 26 of 65 in Drug Manufacturers - Specialty & Generic |
HZNP Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -1.455M | Dec 2011 |
| Maximum | 5.820M | Jun 2010 |
| Average | 0.1049M |
